Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 57 clinical trials
A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB

HBV(hepatitis B virus) with metabolic comorbidities may accelerate liver disease progression and increase the risk of HCC(Hepatocellular Carcinoma)development. It is reported combination of metabolic diseases and CHB is associated with substantially increased rates of liver cirrhosis and secondary liver-related events compared to CHB alone. Consequently, hepatitis B patients with metabolic …

  • 0 views
  • 05 Oct, 2021
  • 1 location
Prospective Evaluation of a Fast-track Treatment Pathway for Patients With Chronic Hepatitis B Under Primary Care

This is a retrospective-prospective longitudinal cohort study, with analyses performed before and after introduction of the pathway, and comparisons made to unexposed controls. We will launch a protocol-driven management for CHB patients, and provide the appropriate assessment tools (transient elastography, HBV DNA assay) to general outpatient clinics (GOPC) in Hong …

  • 0 views
  • 04 Oct, 2022
  • 1 location
A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B

results, family history and prescriptions were recorded. The main criteria for registration is HBsAg-positivity more than 6 months, and these patients will receive followed-up visits every three to six

hepatitis b antigen
antiviral therapy
antiviral drugs
  • 31 views
  • 21 Jan, 2021
  • 45 locations
The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia

only through NA treatment. The long-term follow-up showed that the incidence of HBsAg disappeared by only 2.0% - 0.0% regardless of the long-term treatment of HBsAg. Therefore, the most important

liver cancer
cancer
hepatitis
  • 0 views
  • 27 May, 2022
  • 1 location
The Study on Optimal Treatment and Clinical Outcome of Chronic Hepatitis B Patients With Inactive Hypoviremia

only through NA treatment. The long-term follow-up showed that the incidence of HBsAg disappeared by only 2.0% - 0.0% regardless of the long-term treatment of HBsAg. Therefore, the most important

liver cancer
cancer
hepatitis
  • 0 views
  • 29 May, 2022
  • 1 location
Access HBV Assays - European Union (EU) Clinical Trial Protocol -

The objective of this protocol is the collection and testing of clinical samples to determine the clinical performance of the Access HBV serological marker assays on the DxI 9000 Access Immunoassay Analyzer. The study will involve a multicenter, prospective and retrospective collection of samples, and testing of samples with the …

hepatitis
vaccination
hepatitis b core antibody
  • 0 views
  • 07 Jul, 2022
  • 4 locations
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B

This is a multicenter, prospective, real-world study, recruiting patients with chronic hepatitis B under anti-viral treatment. The recruited participants will receive peginterferon alpha based regimen or nucleos(t)ide alone. The primary objective of this study is to compare the long-term outcomes (including hepatocellular carcinoma, decompensated cirrhosis, etcof different anti-viral therapies. The …

hepatocellular carcinoma
hepatitis
entecavir
cirrhosis
tenofovir
  • 0 views
  • 30 May, 2021
  • 1 location
Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures (SCANVIR)

The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.

Accepts healthy volunteers
  • 0 views
  • 16 May, 2022
  • 1 location
Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- Recipients

clinical experience in living kidney transplantation from HBsAg+ donors to HBsAgrecipients. The follow-up period was 2 years after renal transplantation. The primary outcome was prevention failure of HBV

hepatitis b core antibody
  • 0 views
  • 29 Jul, 2021
  • 1 location
Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

and immunity to HBV1 infection. However, there are several published studies that describe the coexistence of the marker of chronic infection (HBsAg +) and the marker of functional cure (HBsAc

  • 0 views
  • 04 Oct, 2022
  • 1 location